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A commentary on
Research on the immunosuppressive activity of ingredients contained in sunscreens
by: Frikeche, J., Couteau, C., Roussakis, C., and Coiffard, L. J. (2015). Arch. Dermatol. Res. 307,
211–218. doi: 10.1007/s00403-014-1528-9
A recent paper showed that bisabolol contained in cosmetics drastically dampened peripheral blood
lymphocyte proliferation induced by phytohemoagglutinin (PHA) and enhanced the production of
tumor growth factor-beta 1 (TGF-β1) on NCTC 2544 keratinocytes, although it did not change
the activity of monocytes and dendritic cells (Frikeche et al., 2015). The authors showed that
some organic molecules present in sunscreens impaired DC maturation, or inhibited lymphocyte
proliferation as well as increased of TGF-β1 in the cell environment. Alpha-bisabolol [6-methyl-2-
(4-methylcycloex-3-en-1-yl)hept-5-en-2-ol] is a sesquiterpene alcohol, present in different isomers
(Figure 1) that has been described since many years as a promising anti-tumoral compound (da
Silva et al., 2010; Seki et al., 2011) It reduces mammary tumor mass in mice and promotes the
natural killer (NK) cells response (Costarelli et al., 2010). Alpha-bisabolol is present in Matricaria
chamomilla L. essential oils and a potent pro-apoptotic molecule (Cavalieri et al., 2011). The myth
of treating cancer with chamomile extracts would find unexpected support, as this plant contains
flavonoids, as apigenin-7-O-glucoside and other phytochemicals, which act as anti-proliferative
and pro-apoptotic molecules, (Srivastava and Gupta, 2007). Frikeche et al. showed that bisabolol
behaves as a potent immuno-suppressant, an evidence that should raise fundamental issues about
the role of plant-derived molecules on the tumor microenvironment, besides their direct effect on
malignant cells (Frikeche et al., 2015).
Darra et al., reported that the anti-neoplastic action exerted by α-bisabolol, derives
fundamentally by its ability in inducing mitochondria-mediated apoptosis in cancer cells (Darra
et al., 2007, 2008; Cavalieri et al., 2009). In particular, α-bisabolol is preferentially incorporated
into malignant cells through lipid rafts and directly interacts with Bid protein (Darra et al., 2008).
This mechanism, which may account for the reported anti-tumoral effect, has never been assessed
in vivo and particularly Darra’s in vitro evidence did not include the role of immune cells in
the tumor microenvironment during α-bisabolol treatment. Promising results showed that α-
bisabolol is active against primary acute leukemia cells, in synergism with tyrosine inhibitors,
suggesting that its main target is the hematopoietic cell (Cavalieri et al., 2011; Bonifacio et al.,
2012). Frikeche et al. would suggest that the immunosuppressive action performed by α-bisabolol
on lymphocytes may have dramatic consequences on tumor development (Frikeche et al., 2015).
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FIGURE 1 | Alpha-bisabolol different isomers and farnesol, a possible
catabolyte.
Yet, some concern is about α-bisabolol and lipid rafts.
Actually, gamma-delta phenotype T cells (TCR-γδ cells), increase
lipid rafts when activated by involving membrane cholesterol
(Kabouridis et al., 2000; Mahammad et al., 2010; Cheng et al.,
2013). Due to its preferential entry through lipid rafts, α-bisabolol
may induce apoptosis in activated T cells, while simultaneously
switches off lymphocyte activation (Frikeche et al., 2015). Alpha-
bisabolol tropism for immune cells may have fundamental effects
on tumor immune microenvironment, probably by impairing T-
cell activation and lymphocyte switching and promoting cancer
editing, causing evasion from inflammation and generating
immune tolerance (Vinay et al., 2015). Immune suppression
in the tumor microenvironment is fundamentally mediated by
CD4+CD25+FoxP3+ regulatory T cells (Tregs), as the major
mechanism of tumor immune escape, a crucial hurdle for
tumor immunotherapy (Jacobs et al., 2012). Bisabolol enhances
TGF-β in in vitro cultured keratinocytes (Frikeche et al.,
2015) and the cytokine is necessary for the progression of
tumors such as hepatocellular carcinoma, acting by inducing
Tregs polarization (Shen et al., 2015). In melanoma models,
cancer cells induce immune escape and suppression by up-
regulating CD4+CD25+FoxP3+ regulatory T cells, through
TGF-β expression (Baumgartner et al., 2007). If α-bisabolol is
able to increase TGF-β release, its chemopreventive potential
might appear therefore quite controversial. At least apparently,
α-bisabolol might induce immune suppression and tolerance by
increasing the release of cytokines promoting cancer editing.
Furthermore, α-bisabolol does not affect the ability of dendritic
cells (DCs) to produce IL-12p70 (Johansson et al., 2011; Frikeche
et al., 2015). DCs produce IL-12p70 after engulfment of apoptotic
lymphocytes and this mechanism should induce immune
tolerance in the absence of lymphocyte activation (Johansson
et al., 2011). Furthermore, TCR-γδ cells are able to recognize
several unknown antigens on tumor cells. Some metabolites of
the mevalonate pathway, among which is farnesol, a possible
catabolyte of α-bisabolol (Dewick, 2002), should act as tumor
ligands, which can activate TCR-γδ cells (Gober et al., 2003).
The role of TCR-γδ cells in tumors should appear encouraging
(Hannani et al., 2012; Marquez-Medina et al., 2012), but these
cells have also an immunosuppressive role when induced by
TGF-β1 (Gu et al., 2014). Critical points to be addressed regards
therefore the role of this sesquiterpene alcohol on immune
regulation and hence on the immune competence in fighting
cancer. This closely depends on the immune context where
malignant cells are developing, besides to the bioavailability of
α-bisabolol in situ.
Despite its promising activity as an anti-tumor molecule,
α-bisabolol does not possess so different features respect
to the widest family of plant-derived anti-inflammatory and
chemopreventive polyphenols (Chirumbolo, 2010). The ability to
induce cell apoptosis is shared with several other plant derived
compounds, such as quercetin (Primikyri et al., 2014), genistein
(Choi et al., 2007), apigenin (Papachristou et al., 2013), catechins
(Yoon et al., 2014), resveratrol (Wang et al., 2011) and many
others, for which these few examples are reported. The pro-
apoptosis action should be interpreted at the light of the stress
response mechanism activated by cells, a property shared by
any plant-derived polyphenol, representing a general hallmark of
these molecules (Fresco et al., 2010). Tumor cells have critically
different patterns of stress response and they rapidly activate
apoptosis pathway when stimulated by damage or stress signals,
whose burden is particularly difficult to address. In this context
a major role is played by endoplasmic reticulum stress (ER
stress) and the unfolding protein response (UPR), besides to
mitochondria (Maurel et al., 2015).While thesemechanisms shed
a light on the cellular impact of plant phytochemicals, their role
on the cancer immune micro-environment is yet far to be fully
understood. In vitro research usually neglected this issue, as most
of investigations based on cell lines obviously never consider the
immune microenvironment existing in the in vivo situation. In
this perspective, the recent article by Frikeche et al., raises some
criticism about the actual role of α-bisabolol as a real, promising
chemopreventive molecule.
Alpha bisabolol might affect mitochondrial permeability
transition also in non cancer cells (Leanza et al., 2013, 2014)
and recent reports showed a massive death of endothelial cells
by apoptosis induced from 5.0µM α-bisabolol (Magnelli et al.,
2010), a dose about 10-times lower than the one used to
BCR-ABL cell viability in primary acute leukemia (Bonifacio
et al., 2012).
As with other phytochemicals, the role of α-bisabolol on
cancer therapy should be expanded in future debates, while any
further proposals to investigate this organic compound on in
vitro cancer lines, such as MiaPaCa, should be considered with
caution.
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